Evidence map›Paper›PMID 42145348›Full record

ArticleBioinformation2026

AI based prediction of chemotherapy response in cancer patients: A cross-sectional study.

Vipin Kharade, Tapesh Pounikar, Chetna Devkar

Abstract read
In one paragraph

Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vipin KharadeDepartment of Radiation Oncology, All India Institute of Medical Sciences Bhopal, Madhya Pradesh, India.
Tapesh PounikarDepartment of Radiation Oncology, Chhindwara Institute of Medical Sciences, Chinaware, Madhya Pradesh, India.
Chetna DevkarDepartment of Computer Sciences & Engineering, National Institute of Technology, Bhopal, Madhya Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Predicting chemotherapy response remains challenging due to the variability in tumor biology, genetics and host factors. Therefore, it is of interest to evaluate the effectiveness of AI-based predictive models in assessing chemotherapy response in cancer patients. AI models demonstrated high accuracy in distinguishing responders from non-responders, with those integrating multiple data types outperforming single-domain models. The integration of clinical, radiological and laboratory data significantly enhanced prediction accuracy. Therefore, this study advances knowledge by highlighting the potential of AI in revolutionizing chemotherapy response prediction and contributing to more targeted, effective cancer treatments.

Indexed as

Artificial intelligencechemotherapy responsemachine learningoncologypersonalized medicine

Identifiers

PMID42145348
PMCPMC13177158

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.